ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

NASACORT ALLERGY 24HR
Rhinitis/rhinorrhea (intranasal products)
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

NASACORT ALLERGY 24HR OTC

Generic Name and Formulations:
Triamcinolone acetonide 55mcg; per nasal spray; scent- and alcohol-free.

Company:
Chattem Inc.

Therapeutic Use:

Indications for NASACORT ALLERGY 24HR:

Seasonal and perennial allergic rhinitis, including nasal congestion.

Adult:

2 sprays in each nostril once daily. Reduce dose as symptoms improve.

Children:

<2yrs: not recommended. 2–<6yrs: 1 spray in each nostril once daily. 6–12yrs: 1 spray in each nostril once daily; max 2 sprays in each nostril once daily. Reduce dose as symptoms improve.

Warnings/Precautions:

Avoid use in patients with recent nasal ulcers, surgery, or injury that has not healed. Infections (eg, ocular herpes simplex). Glaucoma. Cataracts. Discontinue if exposed to measles, chickenpox, or tuberculosis. Monitor for growth suppression in children. Avoid eyes or mucous membranes. Reevaluate if no improvement after 1 week. Pregnancy. Nursing mothers.

Interactions:

Avoid concomitant other steroid-containing products.

See Also:

CHILDREN'S NASACORT ALLERGY 24HR

Pharmacological Class:

Steroid.

Adverse Reactions:

Infection, fever, visual changes, severe or frequent nosebleeds.

Generic Availability:

NO

How Supplied:

Nasal Spray—8.25g (60 sprays), 16.5g (120 sprays); Children's—8.25g (60 sprays)

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs